Reports from
The Third International Workshop on
Salvage Therapy for HIV Infection
Chicago, April 12-14, 2000

• Report 8 
  Virological and pharmacokinetic rationale for a new salvage regimen: amprenavir (600mg)/saquinavir (800mg)/ritonavir (100mg) twice daily
  
  
• Report 7 
  Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs
  
  
• Report 6 
  Therapy Interruptions and New Data Reported at the Salvage Therapy Workshop
  
  
• Report 5 
  Lactic acidosis complicating antiretroviral therapy: frequency and correlates (abstract 34)
  (4/19/2000)
  
• Report 4 
  Study of L-acetyl-carnitine (LAC) for HIV associated peripheral neuropathy
  (4/19/2000)
  
• Report 3 
  Detecting Resistance When Viral Load is Below 1000 copies/ml
  (4/17/2000)
  
  
• Report 2 
  Salvage Therapy with Dual Protease Inhibitor Regimen Containing Indinavir + Ritonavir Twice Daily
  (4/17/2000)
  
  
• Report 1 
  Mega-HAART When Few Treatment Options Remain (4/17/2000)